Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial (Q38495025)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 2011
edit
Language Label Description Also known as
English
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
scientific article published on October 2011

    Statements

    Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial (English)
    0 references
    0 references
    Michael H Allen
    David Feifel
    Michael D Lesem
    Daniel L Zimbroff
    Ruth Ross
    Patrik Munzar
    Daniel A Spyker
    James V Cassella
    1 October 2011
    1313-1321

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit